Cotrifazid

Cotrifazid
Combination of
Rifampicin	Anti-tuberculosis medication
Isoniazid	Anti-tuberculosis medication
Sulfamethoxazole	Sulfonamide
Trimethoprim	Antibiotic
Clinical data
Pregnancy; category	AU:C;
Routes of; administration	oral
Legal status
Legal status	AU: S4 (Prescription only); UK: POM (Prescription only); US: ℞-only ;

Last updated January 05, 2026

Cotrifazid is a treatment and prophylaxis for malaria consisting of a multiple complex combination of rifampicin, isoniazid, sulfamethoxazole, and trimethoprim.^[1]

References

↑ Freerksen E, Kanthumkumwa EW, Kholowa AR (September–October 1995). "Malaria therapy and prophylaxis with cotrifazid, a multiple complex combination consisting of rifampicin + isoniazid + sulfamethoxazole + trimethoprim". Chemotherapy. 41 (5): 396–398. doi:10.1159/000239372. PMID 8521742.

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

[1] Freerksen E, Kanthumkumwa EW, Kholowa AR (September–October 1995). "Malaria therapy and prophylaxis with cotrifazid, a multiple complex combination consisting of rifampicin + isoniazid + sulfamethoxazole + trimethoprim". Chemotherapy. 41 (5): 396–398. doi:10.1159/000239372. PMID 8521742.

[1]